Human Papilloma Virus Infection in Patients with Male Accessory Gland Infection: Usefulness of the Ultrasound Evaluation

Table 1

Anthropometric measurements and clinical symptom scores in the three groups of patients with male accessory gland infection/inflammation (MAGI) enrolled in this study.

Parameters	MAGI; HPV-positive	MAGI; Chlamydia-positive	Inflammatory MAGI
Anthropometric parameters
Age (years)	26.0 ± 4.0	26.0 ± 8.0	28.0 ± 6.0
BMI (kg/m^2)	21.0 ± 4.0	20.0 ± 3.0	22.0 ± 4.0
Clinical symptoms/signs
Urinary tract symptoms	8.0 ± 4.0	6.0 ± 3.0	6.0 ± 2.0
Spontaneous and/or ejaculatory pain or discomfort	14.0 ± 4.0	13.0 ± 4.0	11.0 ± 3.0
Sexual dysfunction	15.0 ± 4.0	14.0 ± 3.0	12.0 ± 6.0
Impact on the quality-of-life	12.0 ± 4.0	12.0 ± 2.0	10.0 ± 2.0

Urinary tract symptoms severity score: mild: 0–6; moderate: 7–12; severe: 13–18.
Spontaneous and/or ejaculatory pain or discomfort severity score: mild: 0–8; moderate: 9–16; severe: 17–24.
Sexual dysfunction severity score: mild: 0–11; moderate: 12–22; severe: 23–33.
Impact on the quality-of-life severity score: mild: 0–5; moderate: 6–10; severe: 11–15.